Maximon

Maximon Maximon empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions.

The longevity field is advancing rapidly, driven by scientists, clinicians, founders, and investors who are turning deca...
29/04/2026

The longevity field is advancing rapidly, driven by scientists, clinicians, founders, and investors who are turning decades of research into real-world impact. ๐Ÿงฌ

has released its first-ever Rising Stars of Longevity list, highlighting 11 leaders who are helping shape the future of healthy aging across medicine, diagnostics, AI, biotech, and investment.

We are proud that , Founder of Maximon, was part of the expert panel helping evaluate the finalists alongside Andrea B. Maier, Nir Barzilai, Matt Kaeberlein, and Teresa Ghilarducci.

๐Ÿ‘ Congratulations to the 2026 Rising Stars:
Dan Belsky, Evelyne Bischof, MD, PhD, Peter Fedichev, Celine Halioua, Jamie Justice, Ph.D., Nathan LeBrasseur, Morgan Levine, Dylan V. Livingston, Nicole Sirotin, MD DipABLM FACP, Alex Zhavoronkov, and Garri Zmudze.

What makes this list especially exciting is the diversity of perspectives represented. From biological age research and clinical translation to AI-driven discovery, preventive medicine, venture building, and investment.

Each of these leaders contributes to a broader movement: helping people live healthier for longer.

At Maximon, we believe the future of longevity will be built by those who combine rigorous science, entrepreneurial courage, and scalable solutions that can meaningfully improve healthspan.

It is inspiring to see this field gaining global recognition and even more exciting to see the people driving it forward.

Thank you to Business Insider and Hilary Brueck for spotlighting the innovators redefining how we think about aging, prevention, and human potential.๐Ÿ’ก

Dr. Tobias Reichmuth , Founding Partner at Maximon, has been named Founder of the Year 2026 by University of St.Gallen ๐Ÿ†...
31/03/2026

Dr. Tobias Reichmuth , Founding Partner at Maximon, has been named Founder of the Year 2026 by University of St.Gallen ๐Ÿ†

The award was presented at START Summit in St. Gallen and recognises Tobias as a serial entrepreneur and investor who has helped build companies across climate finance, crypto and, more recently, longevity.
For us at Maximon, this recognition is especially meaningful because it highlights a mission we deeply believe in: turning cutting-edge science into real-world solutions that help people stay healthier for longer.
Through Maximon, Tobias has helped build ventures such as AVEA, AYUN and Frieda Health, all part of a broader effort to advance prevention, personalised health and healthy aging. Maximonโ€™s mission is to empower entrepreneurs to build impactful, science-based and scalable companies in healthy aging and rejuvenation.
Congratulations, Tobias, on this well-deserved recognition. ๐Ÿ‘

Is aging a disease or a natural process we can meaningfully influence?โณIn SRF - Schweizer Radio und Fernsehenโ€™s ๐˜š๐˜ต๐˜ฆ๐˜ณ๐˜ฏ๐˜ด๐˜ต๐˜ถ...
12/03/2026

Is aging a disease or a natural process we can meaningfully influence?โณ

In SRF - Schweizer Radio und Fernsehenโ€™s ๐˜š๐˜ต๐˜ฆ๐˜ณ๐˜ฏ๐˜ด๐˜ต๐˜ถ๐˜ฏ๐˜ฅ๐˜ฆ ๐˜—๐˜ฉ๐˜ช๐˜ญ๐˜ฐ๐˜ด๐˜ฐ๐˜ฑ๐˜ฉ๐˜ช๐˜ฆ ๐˜ฆ๐˜ฑ๐˜ช๐˜ด๐˜ฐ๐˜ฅ๐˜ฆ โ€œ๐˜๐˜ด๐˜ต ๐˜ˆ๐˜ญ๐˜ต๐˜ฆ๐˜ณ๐˜ฏ ๐˜ฆ๐˜ช๐˜ฏ๐˜ฆ ๐˜’๐˜ณ๐˜ข๐˜ฏ๐˜ฌ๐˜ฉ๐˜ฆ๐˜ช๐˜ต? รœ๐˜ฃ๐˜ฆ๐˜ณ ๐˜ฅ๐˜ฆ๐˜ฏ ๐˜›๐˜ณ๐˜ข๐˜ถ๐˜ฎ ๐˜ท๐˜ฐ๐˜ฎ ๐˜ญ๐˜ข๐˜ฏ๐˜จ๐˜ฆ๐˜ฏ ๐˜“๐˜ฆ๐˜ฃ๐˜ฆ๐˜ฏโ€, Dr. Tobias Reichmuth joins Thomas Schulz (DER SPIEGEL) for a thoughtful follow-up conversation sparked by the recent SRF longevity documentary.

The interview goes beyond โ€œbiohacking headlinesโ€ and into the real questions the longevity movement has to answer:
โ€ข Where does prevention end and โ€œoptimizationโ€ begin?
โ€ข Whatโ€™s scientifically realistic today and what still belongs in the future?
โ€ข How do we ensure longer lives translate into better lives (for individuals and for society)?

The conversation quickly shifts ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž๐จ๐ซ๐ฒ ๐ญ๐จ ๐ฌ๐จ๐ฆ๐ž๐ญ๐ก๐ข๐ง๐  ๐ฆ๐จ๐ซ๐ž ๐ฉ๐ž๐ซ๐ฌ๐จ๐ง๐š๐ฅ. Tobias shares his own perspective on longevity and a point we strongly agree with: there is ๐ง๐จ ๐จ๐ง๐ž-๐ฌ๐ข๐ณ๐ž-๐Ÿ๐ข๐ญ๐ฌ-๐š๐ฅ๐ฅ ๐›๐ฅ๐ฎ๐ž๐ฉ๐ซ๐ข๐ง๐ญ.
What works for one personโ€™s biology, lifestyle, and goals may not work for anotherโ€™s. Longevity isnโ€™t just a trend, itโ€™s an individual journey shaped by context, genetics, behaviors, and priorities.

Thatโ€™s also why measurement and personalization matter and weโ€™re proud to back AYUN Clinic, where longevity is approached through data-driven diagnostics and tailored longevity check-ups and programs, helping people understand their current health status and make informed, realistic changes based on their markers and needs.

โฌ‡๏ธ Watch the discussion (๐Ÿ”—in comments) and share your view!

๐Ÿ“บ Longevity is moving from niche to mainstream and Swiss public TV is asking the right questions.SRF - Schweizer Radio u...
10/03/2026

๐Ÿ“บ Longevity is moving from niche to mainstream and Swiss public TV is asking the right questions.

SRF - Schweizer Radio und Fernsehen just released the documentary โ€œLongevity โ€“ Auf der Suche nach einem erfรผllten Lebenโ€, following Mona Vetsch and Yves Bossart on a nearly year-long experiment to rethink daily habits, track key health metrics, and explore what it means to live longer and better.

What makes it compelling is that it doesnโ€™t reduce longevity to numbers alone. It connects the science with the very human question of what a ๐Ÿ๐ฎ๐ฅ๐Ÿ๐ข๐ฅ๐ฅ๐ž๐ ๐ฅ๐ข๐Ÿ๐ž looks like.
The film also offers great impressions from their two-day visit to the Longevity Investors Conference (LIC), a reminder that longevity is no longer just a research topic, but an ecosystem where science, entrepreneurship, and capital are converging to accelerate real-world progress.

We also appreciated seeing AYUN Clinic featured. AYUN stands for a proactive, data-driven approach to healthspan, combining advanced diagnostics with medical expertise and practical, personalized guidance. In the episode, assessments and tests were carried out by Dr. Dr. med. Oliver Boekels, Lead Physician at AYUN, helping translate complex biomarkers into clear next steps people can act on.

At Maximon, we build and back ventures that bring longevity science into real-world impact, with one clear focus: extend healthspan, not just lifespan.
Watch the whole coverage (๐Ÿ”— in comments).

Building longevity isnโ€™t just a lab story, itโ€™s also a story of capital, conviction, and the big questions society needs...
06/03/2026

Building longevity isnโ€™t just a lab story, itโ€™s also a story of capital, conviction, and the big questions society needs to debate.

Swiss national TV, Radiotelevisione Svizzera (RSI) just covered the longevity space in Falรฒโ€™s episode โ€œ๐˜๐˜ช๐˜ท๐˜ฆ๐˜ณ๐˜ฆ ๐˜ง๐˜ช๐˜ฏ๐˜ฐ ๐˜ข 140 ๐˜ข๐˜ฏ๐˜ฏ๐˜ช?โ€ and it features Marc P. Bernegger and the Longevity Investors community.

The episode dives into whatโ€™s driving the global race for longer healthspans:
โ€ข why billions are flowing into longevity R&D
โ€ข whatโ€™s real science vs. hype
โ€ข and what it could mean if living to 120+ becomes more than a thought experiment

At Maximon, we build and back ventures that turn breakthrough science into real-world impact, responsibly, and with a long-term mindset.
If youโ€™re curious to see how mainstream this topic has become, watch the segment (๐Ÿ”— link in comments)

Maximonโ€™s Founding Partners Dr. Tobias Reichmuth and Marc P. Bernegger were featured in finews.com: Top stories in conne...
27/02/2026

Maximonโ€™s Founding Partners Dr. Tobias Reichmuth and Marc P. Bernegger were featured in finews.com: Top stories in connection with the Longevity Investors Lunch in Davos, where longevity science meets capital.

Beyond attending, Tobias and Marc are also the ๐Ÿ๐จ๐ฎ๐ง๐๐ž๐ซ๐ฌ ๐š๐ง๐ ๐ก๐จ๐ฌ๐ญ๐ฌ ๐›๐ž๐ก๐ข๐ง๐ ๐‹๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐จ๐ซ๐ฌ ๐š๐ง๐ ๐ข๐ญ๐ฌ ๐ž๐ฏ๐ž๐ง๐ญ๐ฌ, convening builders, researchers and investors to advance the healthspan agenda forward, grounded in science, and focused on real-world impact.

Some of the strongest themes highlighted:

โ€ข ๐”๐ฅ๐ญ๐ซ๐š-๐ฉ๐ž๐ซ๐ฌ๐จ๐ง๐š๐ฅ๐ข๐ณ๐ž๐ ๐ฆ๐ž๐๐ข๐œ๐ข๐ง๐ž: shifting from โ€œaverage humansโ€ to individual biology
โ€ข ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐›๐ฎ๐ข๐ฅ๐๐ข๐ง๐  ๐ก๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ข๐ง๐Ÿ๐ซ๐š๐ฌ๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐ž: from concierge care to integrated ecosystems
โ€ข ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž 3.0 ๐š๐ง๐ ๐€๐ˆ-๐ž๐ง๐š๐›๐ฅ๐ž๐ ๐ฉ๐ซ๐ž๐ฏ๐ž๐ง๐ญ๐ข๐จ๐ง: moving from reactive care to proactive optimisation
A needed reminder to stay evidence-based, including caution around ๐ฐ๐ž๐ฅ๐ฅ๐ง๐ž๐ฌ๐ฌ ๐ˆ๐•๐ฌ and questionable supplementation

Tobias and Marc also delivered the ๐œ๐ฅ๐จ๐ฌ๐ข๐ง๐  ๐ฌ๐ฉ๐ž๐ž๐œ๐ก, reflecting on what it takes to turn frontier science into scalable healthspan outcomes.

๐Ÿ”— Weโ€™ll share the article and event background links in the comments.

Our Founding Partner Marc P. Bernegger sat down with GstaadLife Magazine for a thoughtful conversation about whatโ€™s chan...
23/02/2026

Our Founding Partner Marc P. Bernegger sat down with GstaadLife Magazine for a thoughtful conversation about whatโ€™s changing in longevity and what should change next.

What we appreciate about the interview is its focus on ๐ฌ๐ฎ๐›๐ฌ๐ญ๐š๐ง๐œ๐ž ๐จ๐ฏ๐ž๐ซ ๐ฌ๐ญ๐จ๐ซ๐ฒ๐ญ๐ž๐ฅ๐ฅ๐ข๐ง๐ :

โ€ข ๐‘๐ข๐ ๐จ๐ฎ๐ซ ๐จ๐ฏ๐ž๐ซ ๐ก๐ฒ๐ฉ๐ž: longevity needs measurable outcomes, strong science, and responsible delivery and not โ€œmiracleโ€ marketing.

โ€ข ๐…๐ซ๐จ๐ฆ ๐ง๐ข๐œ๐ก๐ž ๐ญ๐จ ๐ฆ๐š๐ข๐ง๐ฌ๐ญ๐ซ๐ž๐š๐ฆ: real impact comes when proven tools become accessible, affordable, and integrated into everyday healthcare.

โ€ข ๐‡๐ž๐š๐ฅ๐ญ๐ก๐ฌ๐ฉ๐š๐ง ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฉ๐จ๐ข๐ง๐ญ: extending life only matters if we extend quality of life with prevention, diagnostics, and interventions that people can actually use.

โ€ข ๐€ ๐Ÿ๐ข๐ž๐ฅ๐ ๐ฆ๐š๐ญ๐ฎ๐ซ๐ข๐ง๐  ๐Ÿ๐š๐ฌ๐ญ: the tone is shifting toward standards, scalability, and long-term value creation, exactly where the industry needs to go.

If you want a great read that cuts through the noise (and captures the spirit of the Longevity Investors Conference in Gstaad), this one is worth your time.
๐Ÿ‘‡ Read it here (link in comments)

๐๐ž๐ฐ ๐จ๐ง ๐ญ๐ก๐ž ๐Œ๐š๐ฑ๐ข๐ฆ๐จ๐ง ๐›๐ฅ๐จ๐ : ๐๐ข๐ญ๐œ๐จ๐ข๐ง ๐ฆ๐ž๐ž๐ญ๐ฌ ๐‹๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ - ๐–๐ก๐ž๐ซ๐ž ๐๐ข๐ฌ๐ซ๐ฎ๐ฉ๐ญ๐ข๐จ๐ง ๐ฆ๐ž๐ž๐ญ๐ฌ ๐๐ž๐Ÿ๐ข๐š๐ง๐œ๐ž โ‚ฟ ๐Ÿงฌ We just published a deeper write-...
16/02/2026

๐๐ž๐ฐ ๐จ๐ง ๐ญ๐ก๐ž ๐Œ๐š๐ฑ๐ข๐ฆ๐จ๐ง ๐›๐ฅ๐จ๐ : ๐๐ข๐ญ๐œ๐จ๐ข๐ง ๐ฆ๐ž๐ž๐ญ๐ฌ ๐‹๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ - ๐–๐ก๐ž๐ซ๐ž ๐๐ข๐ฌ๐ซ๐ฎ๐ฉ๐ญ๐ข๐จ๐ง ๐ฆ๐ž๐ž๐ญ๐ฌ ๐๐ž๐Ÿ๐ข๐š๐ง๐œ๐ž โ‚ฟ ๐Ÿงฌ

We just published a deeper write-up of Marc P. Berneggerโ€™s talk from Luganoโ€™s Plan โ‚ฟ Forum and why the overlap between crypto and longevity is becoming an investable, buildable frontier.

In the article, we explore:
โ€ข ๐–๐ก๐ฒ โ€œ๐Ÿ๐ข๐ง๐š๐ง๐œ๐ข๐š๐ฅ ๐ž๐ง๐ญ๐ซ๐จ๐ฉ๐ฒโ€ ๐š๐ง๐ โ€œ๐›๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐๐ž๐œ๐š๐ฒโ€ ๐ซ๐ก๐ฒ๐ฆ๐ž (and why both are being challenged)
โ€ข How cryptoโ€™s builder mindset is showing up in ๐š๐ ๐ž ๐ซ๐ž๐ฏ๐ž๐ซ๐ฌ๐š๐ฅ, ๐œ๐ซ๐ฒ๐จ๐ง๐ข๐œ๐ฌ, ๐š๐ง๐ ๐ซ๐š๐๐ข๐œ๐š๐ฅ ๐ฅ๐ข๐Ÿ๐ž ๐ž๐ฑ๐ญ๐ž๐ง๐ฌ๐ข๐จ๐ง
โ€ข How ๐ƒ๐ž๐’๐œ๐ข (Decentralized Science) is reshaping research funding and collaboration and what that could mean for biotech breakthroughs
โ€ข What this convergence means for founders, investors, and anyone thinking long-term

If youโ€™re curious where capital, coordination, and science are heading next, have a look into it!
๐Ÿ‘‰ ๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐›๐ฅ๐จ๐  ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž on Maximonโ€™s website!

๐ƒ๐š๐ฏ๐จ๐ฌ ๐ฌ๐ก๐จ๐ฐ๐ž๐ ๐ข๐ญ ๐š๐ ๐š๐ข๐ง: ๐ฅ๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ ๐ข๐ฌ ๐ง๐จ ๐ฅ๐จ๐ง๐ ๐ž๐ซ ๐š ๐ง๐ข๐œ๐ก๐ž, ๐ข๐ญโ€™๐ฌ ๐›๐ž๐œ๐จ๐ฆ๐ข๐ง๐  ๐š๐ง ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐š๐ง๐ ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ฉ๐ซ๐ข๐จ๐ซ๐ข๐ญ๐ฒ. ๐Ÿงฌ๐Ÿ”๏ธDuring th...
22/01/2026

๐ƒ๐š๐ฏ๐จ๐ฌ ๐ฌ๐ก๐จ๐ฐ๐ž๐ ๐ข๐ญ ๐š๐ ๐š๐ข๐ง: ๐ฅ๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ ๐ข๐ฌ ๐ง๐จ ๐ฅ๐จ๐ง๐ ๐ž๐ซ ๐š ๐ง๐ข๐œ๐ก๐ž, ๐ข๐ญโ€™๐ฌ ๐›๐ž๐œ๐จ๐ฆ๐ข๐ง๐  ๐š๐ง ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐š๐ง๐ ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ฉ๐ซ๐ข๐จ๐ซ๐ข๐ญ๐ฒ. ๐Ÿงฌ๐Ÿ”๏ธ

During the World Economic Forum this week, the Longevity Investors Lunch took place in Davos, hosted by Dr. Tobias Reichmuth and Marc P. Bernegger, Founders of Maximon.

Longevity Investors is building a ๐ฉ๐ซ๐ž๐ฆ๐ข๐ž๐ซ ๐ฉ๐ฅ๐š๐ญ๐Ÿ๐จ๐ซ๐ฆ to connect a ๐ฌ๐ž๐ฅ๐ž๐œ๐ญ๐ž๐ ๐ ๐ซ๐จ๐ฎ๐ฉ ๐จ๐Ÿ ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐จ๐ซ๐ฌ ๐š๐ง๐ ๐ฅ๐ž๐š๐๐ž๐ซ๐ฌ who want to advance collaboration and capital allocation in ๐ฅ๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ ๐ฌ๐œ๐ข๐ž๐ง๐œ๐ž and the lunch created exactly that. A focused setting for candid conversations between funds, entrepreneurs, and scientists.

Thank you to everyone who joined, it was a high-quality, successful gathering with many prestigious attendees and a lot of momentum to build on.

๐Ÿ“ธ Weโ€™ll be sharing a few snapshots from the lunch below.

๐Ÿ‘‰ Next stop: Longevity Investors Conference, see you there!

๐…๐š๐ฆ๐ข๐ฅ๐ฒ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐ฑ ๐‹๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ: ๐ฐ๐ก๐š๐ญ ๐ ๐ž๐ญ๐ฌ ๐Ÿ๐ฎ๐ง๐๐ž๐ ๐ฌ๐ก๐š๐ฉ๐ž๐ฌ ๐ฐ๐ก๐š๐ญ ๐ฌ๐œ๐š๐ฅ๐ž๐ฌ ๐Ÿงฌ On January 19, 2026, Maximon Co-Founder Marc P....
16/01/2026

๐…๐š๐ฆ๐ข๐ฅ๐ฒ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐ฑ ๐‹๐จ๐ง๐ ๐ž๐ฏ๐ข๐ญ๐ฒ: ๐ฐ๐ก๐š๐ญ ๐ ๐ž๐ญ๐ฌ ๐Ÿ๐ฎ๐ง๐๐ž๐ ๐ฌ๐ก๐š๐ฉ๐ž๐ฌ ๐ฐ๐ก๐š๐ญ ๐ฌ๐œ๐š๐ฅ๐ž๐ฌ ๐Ÿงฌ

On January 19, 2026, Maximon Co-Founder Marc P. Bernegger will join a Longevity Panel at the Family Offices and Investors Summit 2026 (World Economic Forum week side event), alongside legendary Silicon Valley investor Dr. Bill Tai.

Longevity is shifting from a future narrative to a present investment category:
from breakthrough science โ†’ to products, platforms, and protocols that can meaningfully extend healthspan. But the question is no longer โ€œIs longevity real?โ€, itโ€™s:

โ€ข ๐–๐ก๐ข๐œ๐ก ๐š๐ฉ๐ฉ๐ซ๐จ๐š๐œ๐ก๐ž๐ฌ ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ž ๐๐ฎ๐ซ๐š๐›๐ฅ๐ž? (data, biomarkers, outcomes)
โ€ข ๐–๐ก๐š๐ญโ€™๐ฌ ๐ก๐ฒ๐ฉ๐ž ๐ฏ๐ฌ. ๐œ๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐  ๐š๐๐ฏ๐š๐ง๐ญ๐š๐ ๐ž? (distribution, regulation, trust)
โ€ข ๐‡๐จ๐ฐ ๐๐จ๐ž๐ฌ ๐œ๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐š๐œ๐œ๐ž๐ฅ๐ž๐ซ๐š๐ญ๐ž ๐ซ๐ž๐ฌ๐ฉ๐จ๐ง๐ฌ๐ข๐›๐ฅ๐ž ๐ฌ๐œ๐š๐ฅ๐ž? (from labs to real lives)

Family offices are uniquely positioned here: long-term thinking, patient capital, and the ability to back teams building through cycles, not just trends.

If youโ€™re attending and want to compare notes on longevity investing, diagnostics, therapeutics, or venture building, come by!
More information on the events in the comments below ๐Ÿ‘‡

Adresse

Bahnhofplatz
Zug
6300

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Maximon erfรคhrt. Ihre E-Mail-Adresse wird nicht fรผr andere Zwecke verwendet und Sie kรถnnen sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Maximon senden:

Verknรผpfungen

Teilen

Kategorie